Cargando…

Reversal of Oral Anticoagulants: A Survey of Contemporary Practice Trends (ReACT)

This study evaluated practice patterns and factors influencing treatment decisions regarding urgent or emergent reversal of oral anticoagulants (OACs). A 30-question survey was electronically distributed to anticoagulation members of the Anticoagulation Forum. Questions were designed to capture prac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Huiwen, Nutescu, Edith A., DiDomenico, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259145/ https://www.ncbi.nlm.nih.gov/pubmed/37272034 http://dx.doi.org/10.1177/10760296231176808

Ejemplares similares

ReAct Toolbox
Publicado: (2019)

Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study
por: Zhang, Chi, et al.
Publicado: (2022)

Management of Haemarthrosis in Patients On Oral Anticoagulants
por: Dalrymple, James, et al.
Publicado: (2022)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Costs and Healthcare Resource Utilization Associated with Idarucizumab or Andexanet Alfa Oral Anticoagulant Reversal in Patients Hospitalized with Life-Threatening Bleeds
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Oral Anticoagulant and Antiplatelet Therapy for Cervical Artery Dissection: A Meta-Analysis of Clinical Trials
por: Ye, Sheng-Lin, et al.
Publicado: (2021)

Evaluation of Patient Characteristics Linked to Major Bleeding Events in Patients Prescribed Direct Oral Anticoagulants
por: Kanaan, Dareen M., et al.
Publicado: (2023)

An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation
por: Shen, Nan-Nan, et al.
Publicado: (2023)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
por: Srikajornlarp, Saowaluk, et al.
Publicado: (2022)

Evaluation of DOAC Dipstick Test for Detecting Direct Oral Anticoagulants in Urine Compared with a Clinically Relevant Plasma Threshold Concentration
por: Örd, Lenna, et al.
Publicado: (2022)

Prevention of nNon-Vitamin K Oral Anticoagulants-Related Gastrointestinal Bleeding With Acid Suppressants: A Systematic Review and Meta-Analysis
por: Dong, Yongqi, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulants in Stable Coronary Artery Disease and Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
por: Ma, Fang, et al.
Publicado: (2022)

Retrospective Analysis of the Real-World Utilization of 4-Factor Prothrombin Complex Concentrate and Plasma in Oral Anticoagulant-Associated Bleeding in US Hospitals
por: Refaai, Majed A., et al.
Publicado: (2023)

Comparing Vitamin K Antagonists and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis
por: Lee, Wei-Chieh, et al.
Publicado: (2023)

Development of the PROMIS-based Research Assessment and Clinical Tool-Fatigue (ReACT-F)
por: Dickinson, Kristin A., et al.
Publicado: (2019)

Risk of device-related thrombosis following short-term oral anticoagulation with low-dose dabigatran versus warfarin after Watchman left atrial appendage occlusion
por: Ge, Heng, et al.
Publicado: (2022)

Pharmacology of anticoagulants used in the treatment of venous thromboembolism
por: Nutescu, Edith A., et al.
Publicado: (2016)

Long-term Anticoagulation with Apixaban in Patients with Cerebral Venous Thrombosis
por: Bharath, Suman Preet, et al.
Publicado: (2023)

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey
por: Nabulsi, Nadia A, et al.
Publicado: (2022)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
por: Kornfehl, Andrea, et al.
Publicado: (2023)

Erratum to: Pharmacology of anticoagulants used in the treatment of venous thromboembolism
por: Nutescu, Edith A., et al.
Publicado: (2016)

Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version
por: Qneibi, Dalia, et al.
Publicado: (2020)

Age Is Associated With the Efficacy of Anticoagulant Therapies Against Sepsis-Induced Disseminated Intravascular Coagulation
por: Takahashi, Kyosuke, et al.
Publicado: (2021)

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists
por: Rodriguez, Vilmarie, et al.
Publicado: (2022)

Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019)

Assessment of Healthcare Resource Utilization by Anticoagulant Heparinoid Dosage Level in Patients Hospitalized with COVID-19
por: Robinson, Keith, et al.
Publicado: (2022)

Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
por: Smit, Bob, et al.
Publicado: (2023)

Reversal of direct oral anticoagulants
por: Almegren, Mosaad
Publicado: (2017)

MPs-ACT, an Assay to Evaluate the Procoagulant Activity of Microparticles
por: Gao, Yalong, et al.
Publicado: (2023)

Circadian (re)colonisation dynamics of macroinvertebrates in an isolated karst spring
por: Bućan, Denis, et al.
Publicado: (2023)

Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
por: Woo, Suhyeon, et al.
Publicado: (2022)

Implementation of the Management of Anticoagulation in the Periprocedural Period App into an Electronic Health Record: A Cost-Effectiveness Analysis
por: Wang, Jason J., et al.
Publicado: (2023)

Anticoagulation Therapy for Splanchnic Vein Thrombosis Associated With Acute Pancreatitis: A Systematic Review and Meta-Analysis
por: Yin, Yuhang, et al.
Publicado: (2023)

Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
por: Yan, Xiaodi, et al.
Publicado: (2023)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia
por: Yimer, Nuredin Shiferaw, et al.
Publicado: (2021)

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vicddvm2d2lekl3m8ji68h3nv6